Technical Analysis for REPH - Recro Pharma, Inc.

Grade Last Price % Change Price Change
grade A 7.99 1.27% 0.10
REPH closed up 1.27 percent on Friday, January 18, 2019, on 72 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical REPH trend table...

Date Alert Name Type % Chg
Jan 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 17 Outside Day Range Expansion 1.27%
Jan 17 Up 3 Days in a Row Strength 1.27%
Jan 16 Narrow Range Bar Range Contraction 2.17%
Jan 16 NR7 Range Contraction 2.17%
Jan 16 NR7-2 Range Contraction 2.17%
Jan 16 Inside Day Range Contraction 2.17%

Older signals for REPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Recro Pharma, Inc., a clinical stage specialty pharmaceutical company, is engaged in the development of various non-opioid therapeutics for the treatment of pain and related conditions in the United States. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. It has a license agreement with Orion Corporation for the development and commercialization of Dex and Fado. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was founded in 2007 and is based in Malvern, Pennsylvania.
Is REPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.05
52 Week Low 4.78
Average Volume 139,676
200-Day Moving Average 7.3663
50-Day Moving Average 7.2271
20-Day Moving Average 7.507
10-Day Moving Average 7.918
Average True Range 0.3999
ADX 29.54
+DI 26.6165
-DI 10.7323
Chandelier Exit (Long, 3 ATRs ) 7.3003
Chandelier Exit (Short, 3 ATRs ) 7.8897
Upper Bollinger Band 8.4735
Lower Bollinger Band 6.5405
Percent B (%b) 0.75
BandWidth 25.749301
MACD Line 0.2193
MACD Signal Line 0.1978
MACD Histogram 0.0216
Fundamentals Value
Market Cap 152.28 Million
Num Shares 19.1 Million
EPS -2.12
Price-to-Earnings (P/E) Ratio -3.77
Price-to-Sales 2.35
Price-to-Book 2.89
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.31
Resistance 3 (R3) 8.28 8.15 8.25
Resistance 2 (R2) 8.15 8.07 8.16 8.23
Resistance 1 (R1) 8.07 8.02 8.11 8.10 8.22
Pivot Point 7.94 7.94 7.96 7.95 7.94
Support 1 (S1) 7.86 7.86 7.90 7.89 7.76
Support 2 (S2) 7.73 7.81 7.74 7.75
Support 3 (S3) 7.65 7.73 7.73
Support 4 (S4) 7.68